Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a randomized double-blind placebo-controlled study of CD-800 for lumbar radiculopathy
MOH_2019-11-18_008493Phase 2Not yet recruiting
- Sponsor
- Canndoc
- Start
- Oct 2019
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in lumbosacral radiculopathy comparing CD-800 with Placebo (2 arms). Planned start Oct 2019; status: not yet recruiting.
02
Drugs
CD-800
03
Conditions
lumbosacral radiculopathy
Beyond the preview
Go deeper on MOH_2019-11-18_008493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2019-11-18_008493.